Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies

被引：0
|
作者：
Pishoy Gouda
Sijia Zheng
Tricia Peters
Marat Fudim
Varinder Kaur Randhawa
Justin Ezekowitz
Thomas A. Mavrakanas
Nadia Giannetti
Michael Tsoukas
Renato Lopes
Abhinav Sharma
机构：
[1] University of Alberta,Department of Medicine, Division of Cardiology
[2] McGill University Health Centre,Department of Medicine
[3] Lady Davis Institute for Medical Research,Centre for Clinical Epidemiology
[4] The Jewish General Hospital,Division of Endocrinology, Department of Medicine
[5] McGill University,Department of Medicine, Duke Clinical Research Institute
[6] Duke University Medical Center,Department of Cardiovascular Medicine, Kaufman Center for Heart Failure and Recovery
[7] Cleveland Clinic Foundation,Division of Nephrology, Department of Medicine
[8] Canadian VIGOUR Centre,Division of Endocrinology
[9] McGill University Health Centre and Research Institute,undefined
[10] McGill University Health Centre,undefined
来源：
Current Heart Failure Reports | 2021年 / 18卷
关键词：
Diabetes; Phenotypes; Cardiovascular outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 263
页数：10
相关论文
共 50 条
  • [31] Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes From a Health Care Database
    Swindle, Jason P.
    Ye, Xin
    Mallick, Rajiv
    Song, Rui
    Horstman, Thomas
    Bays, Harold E.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (07) : 847 - 855
  • [32] Clinical characteristics and outcomes of pulmonary tuberculosis in patients with diabetes mellitus
    Hedhli, Abir
    Racil, Hajer
    Habibech, Sonia
    Bacha, Saoussen
    Cheikhrouhou, Sana
    Chaouch, Naouel
    Chabbou, Abdellatif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Clinical characteristics of bacterial liver abscess in patients with type 2 diabetes mellitus
    张慧
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (03) : 150 - 151
  • [34] Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone
    Li, Yan-Rong
    Wang, Chih-Ching
    Liu, Chi-Hung
    Yen, Chieh-Li
    Wu, Victor Chien-Chia
    Huang, Evelyn Jou-Chen
    Lee, Ching-Yu
    Hsiao, Ching-Chung
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [35] Treatment of type 2 diabetes mellitus patients with insulin: Possible lowering of protective effect of female gender on the cardiovascular outcomes?
    Khalangot, Mykola
    Kravchenko, Victor
    PHARMACOLOGICAL RESEARCH, 2017, 123 : 145 - 145
  • [36] The clinical outcomes of nursing intervention for children with type 2 diabetes mellitus on the treatment adherence
    Ba, Hezang
    Yu, Xinxin
    Han, Shuzhen
    Kang, Lijuan
    Xu, Chuanwei
    Xue, Rongyan
    Li, Mingyu
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (15): : 6916 - 6919
  • [37] Dapagliflozin Treatment for Type 2 Diabetes Mellitus Patients With Comorbid Cardiovascular Disease and Hypertension
    Cefalu, William T.
    Leiter, Lawrence A.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    DIABETES, 2012, 61 : A271 - A271
  • [38] New dyslipemic phenotypes in patients with type 2 diabetes mellitus.
    Wägner, AM
    Calvo, F
    Castellvi, A
    Rigla, M
    Bonet, R
    Ordóñez, J
    Pérez, A
    DIABETOLOGIA, 1998, 41 : A346 - A346
  • [39] Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
    Hertzel C Gerstein
    Salim Yusuf
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 798 - 799
  • [40] Cardiovascular morbidity precedes oral antidiabetic treatment in patients with diabetes mellitus type 2
    Erkens, JA
    Herings, RMC
    Stolk, RP
    Spoelstra, JA
    Grobbee, DE
    Leufkens, HGM
    DIABETOLOGIA, 2000, 43 : A280 - A280
12345